Leonard E. Post - 17 Jul 2025 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Reporting relationship: Director
Issuer ticker: CGON
Reported as of: 17 Jul 2025
Net transaction value: -$54,800
SEC form: 4
Accepted by SEC: 18 Jul 2025, 16:30:05 UTC
Prior SEC filing: 24 Jun 2025
Next SEC filing: 04 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post

Key filing fact

Leonard E. Post filed Form 4 for CG Oncology, Inc. (CGON) on 18 Jul 2025.

Key facts

This page summarizes Leonard E. Post's Form 4 filing for CG Oncology, Inc. (CGON).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Jul 2025, 16:30.

Change

Previous filing in this sequence was filed on 24 Jun 2025.
Current net transaction value: -$54,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001235862 Primary reporting owner

POST LEONARD E

Relationship: Director
Address: C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE
Signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post
Signature date: 18 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGON transaction

Common Stock

Options Exercise

Transaction value: $1,200
Shares: +2,000
Change %
Price: $0.6000
Shares after: 2,000
Date: 17 Jul 2025
Ownership: Direct

CGON transaction

Common Stock

Sale

Transaction value: $56,000
Shares: -2,000
Change %: -100%
Price: $28.00
Shares after: 0
Date: 17 Jul 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGON transaction Derivative

Director Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -2,000
Change %: -1.6%
Price: $0.000000
Shares after: 126,077
Date: 17 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000
Exercise price: $0.6000
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.

Footnote F2

Fully vested